Refine by
Laboratory Data Articles & Analysis
45 news found
Following the generation of successful results with the University of Michigan through the ACE program, Predictive Oncology is now actively calling for submissions for a new cohort of compounds to be tested in Q4 2025. ACE program participation is offered exclusively to academic institutions and provides access to the POAI proprietary active ML/AI and biobank of primary patient ...
Additionally, through a dedicated real-world evidence study, researchers will be able to evaluate the operational benefits of liquid biopsy testing, including the speed of results and the ability of users to consistently achieve high-quality data in a variety of laboratory settings. “Our collaboration with AstraZeneca has the potential to dramatically ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update from the Company’s work with biopharma company Boundless Bio. ...
We’ll design the most appropriate technology combination according to your project and help researchers obtain higher-quality scientific research data,” he further added. About Creative Proteomics Creative Proteomics is an innovative contract research organization that focuses on using advanced equipment platforms and optimized detection technologies to help ...
This enabled IVS’s scientific team to continue critical proof of concept studies to build a strong foundation for commercialization. Strong scientific data led to the establishment of collaborative strategic partnerships. ...
We will choose the right technology combination according to your project and help researchers obtain higher-quality scientific research data,” he further added. About Creative Proteomics Creative Proteomics is an innovative contract research organization that focuses on using advanced equipment platforms and optimized detection technology to help researchers around the ...
The company has a proprietary laboratory information management system to strengthen laboratory quality monitoring and quality management and ensure the efficiency and security of customer data. ...
You will no longer have to wait for days for a central diagnostic laboratory to provide critical medical test data regarding your health. ...
RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International Space Station U.S. National Laboratory (ISS National Lab). This experiment will examine the biomaterial's osteoconductivity when used in a microgravity environment where bone density and the ability to regenerate new bone tissue is significantly ...
We will choose the most proper technology combination according to your project, meet your various needs, and help researchers obtain higher-quality scientific research data,” stated Creative Proteomics’s senior scientist. “To identify specific cytokines involved in any inflammatory or immune response, we often need to screen for cytokines, which requires ...
V-Wave Ltd, manufacturer of the V-Wave Ventura investigational interatrial shunt device to help patients with advanced heart failure (HF), announced 12-month echocardiographic results from the open label Roll-in arm of the RELIEVE-HF pivotal clinical trial, comprising 97 NYHA Class III or ambulatory Class IV HF patients who were already on maximally tolerated guideline directed medical therapy. ...
We will choose the right technology combination according to your project, meet your various needs, and help researchers obtain higher-quality scientific research data,” stated Creative Proteomics’s senior scientist. Creative Proteomics can provide a tumor necrosis factor detection platform for scientific research. ...
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics recently launched various types of genotyping analysis services, including ...
Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation. ...
Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data. Cytokines, including interleukins, interferons, tumor necrosis factors, and chemokines, can play key pro- and anti-inflammatory roles in vivo through a variety of biochemical pathways and interactions. ...
This partnership will also add a new state-of-the-art dedicated laboratory to accelerate the advancement of Amgen’s R&D projects. ...
ByBiocon
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview ...
“Clinical research has been a number one priority for our practice since our doors opened almost 40 years ago. We’ve worked hard to build and expand our clinical trial program so that all of our patients have every possible option to receive access to the newest therapies in development,” said Steven Duffy, MD at HOA CNY. “We’re delighted to partner with Deep Lens ...
The company has a proprietary laboratory information management system to strengthen laboratory quality monitoring and quality management to ensure the efficiency and security of customer data. ...
On December 22, 2021, the Food and Drug Administration (FDA) indicated that data generated in preliminary RADx laboratory studies, with heat-inactivated Omicron samples, suggested that the QuickVue antigen tests are able to detect the Omicron variant with similar performance as with other variants. Additional testing has now been completed by the same ...